Ritholtz Wealth Management decreased its position in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by ...

Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) shot up 7.6% during mid-day trading on Monday after Raymond James raised their price target on the stock from $26.00 to $28.00.

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand ... paradigm for each individual” and determine the best way for them to manage the disease. According to Martin ...

9NEWS Medical Expert Dr. Payal Kohli weighs in on a new nasal spray being used to treat depression. 14 Outdated Home Trends That Are Lowering Your Property Value ...

The results? A nasal spray of oxytocin significantly reduced acute feelings of loneliness in participants, especially during group therapy sessions, even months after treatment. In the study ...

Now, the Food and Drug Administration (FDA) has expanded approval for Johnson & Johnson's nasal spray, Spravato ... if this treatment option is the best for you. Korin Miller is a writer ...